28例中国V型成骨不全患者临床特征的回顾性分析:旧问题的新视角
该回顾性研究纳入28例于香港大学深圳医院住院的V型成骨不全患者(临床诊断或经IFITM5 c.-14C>T突变基因确诊),系统描述其骨骼表型:桡骨头脱位、骨间膜钙化、增生性骨痂、脊柱侧弯等,并发现肘关节、髋关节及生长板异常等新表型;双膦酸盐治疗可显著提高骨密度。
要点
- V型成骨不全影像学特征:桡骨头脱位100%、骨间膜钙化100%、增生性骨痂44%、脊柱侧弯50%。
- 新发现骨骼表型包括冠突延伸、髋臼唇、髋臼突出、髋关节自发融合、球状骨骺、爆米花样钙化。
- 术前使用吲哚美辛的12例中3例(25%)术后发生增生性骨痂,2例年轻患者2年后骨痂吸收。
核心结论
- 该回顾性研究总结了V型成骨不全患者的临床特征,突出肘关节、髋关节及生长板异常,丰富了该病的临床谱。
- 研究描述了不同年龄患者增生性骨痂形成与吸收的自然进程,双膦酸盐治疗可有效改善V型成骨不全患者的骨密度。
- 吲哚美辛能否降低增生性骨痂发生率值得进一步研究。
研究设计与样本
- 回顾性研究,纳入28例于香港大学深圳医院住院的V型成骨不全患者,诊断依据为临床诊断或IFITM5 c.-14C>T突变基因确诊。
主要发现
- V型成骨不全影像学特征发生率与既往文献相当:桡骨头脱位100%、骨间膜钙化100%、增生性骨痂44%、脊柱侧弯50%。
- 新发现的骨骼表型包括冠突延伸、髋臼唇、髋臼突出、髋关节自发融合、球状骨骺及爆米花样钙化。
- 双膦酸盐治疗患者骨密度显著增加。
- 术前使用吲哚美辛的12例患者中3例(25%)术后发生增生性骨痂,2例年轻患者2年后骨痂吸收。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Type V osteogenesis imperfecta (OI) is a form of OI characterized by radial head dislocation (RHD), calcification of interosseous membrane (CIM), and hyperplastic callus (HPC). In this study, we characterized the clinical features of 28 type V OI patients. We presented that dysfunctions of elbow, hip joint, and abnormal epiphyseal growth plate were associated with ectopic calcification and summarized the history of HPC progression and treatment. INTRODUCTION: The current study aims to systematically characterize the skeletal phenotypes of patients with type V OI and suggested possible surgical solutions. METHODS: A total of 28 patients were admitted for inpatient care at The Hong Kong University-Shenzhen Hospital diagnosed with type V OI (either clinically diagnosed or genetically confirmed with the IFITM5 c.-14C > T mutation). RESULTS: Prevalence of type V radiological features was comparable to previous literatures (RHD, 100%; CIM, 100%; HPC, 44%; and scoliosis, 50%). Novel skeletal phenotypes were presented including extension of coronoid process, acetabular labrum, acetabular protrusion, spontaneous autofusion of the hip, bulbous epiphysis, and popcorn calcification. Significant increase in BMD was observed in patients with bisphosphonate treatment. Twenty-five percent (3/12) of patients with preoperative use of indomethacin developed HPC postoperatively, and HPCs were absorbed in 2 young patients 2 years later. CONCLUSION: This retrospective study summarized the clinical features and highlighted the abnormalities in elbow, hip joint, and growth plate in type V OI patients. Our study contributed to a more comprehensive clinical spectrum of type V OI. We also characterized the natural progression of HPC formation and resorption in patients in different ages. The use of bisphosphonate treatment is effective in improving bone mineral density in type V OI patients, and whether indomethacin can reduce incidence of HPC formation deserves further investigation.
引用
- Tan Z, Shek HT, Dong Z, et al. Retrospective analyses of clinical features in 28 Chinese patients with type V osteogenesis imperfecta: new perspectives in an old issue. Osteoporos Int. 2022. PMID: 36456709. doi:10.1007/s00198-022-06581-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。